Point of Care Testing, An Issue of the Clinics in Laboratory Medicine

1st Edition, Volume 43-2 - May 14, 2023
Editor: Linoj Samuel
Language: English
Hardback ISBN:
9 7 8 - 0 - 4 4 3 - 1 8 2 9 4 - 5
eBook ISBN:
9 7 8 - 0 - 4 4 3 - 1 8 2 9 5 - 2

In this issue of Clinics in Laboratory Medicine, guest editor Dr. Linoj Samuel brings his considerable expertise to the topic of Point of Care Testing. Top experts discuss the… Read more

Point of Care Testing, An Issue of the Clinics in Laboratory Medicine

Purchase options

Info / Buy

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

In this issue of Clinics in Laboratory Medicine, guest editor Dr. Linoj Samuel brings his considerable expertise to the topic of Point of Care Testing. Top experts discuss the challenges, techniques, and data collection for point of care and at-home testing options for COVID-19, fungal pathogens, and STDs in various demographics, among other key topics.

Cover image
Title page
Table of Contents
Copyright
Contributors
Forthcoming Issues
Preface
Regulatory Approach to Point-of-Care/At-Home Testing in the United States
Key points
Introduction
History
COVID point-of-care and home testing
The future of point-of-care, near patient testing, and at-home testing
Summary
Clinics care points
Disclosure
Practical Challenges of Point-of-Care Testing
Key points
Introduction
Clinical application
Point-of-care testing versus central laboratory tests
Economics of point-of-care testing adoption
Point-of-care testing location
Staffing
Quality
Preanalytical and analytical factors
Postanalytical factors (reporting of point-of-care testing results)
Implementing a quality management system
Summary
Clinics care points
Disclosure
Will Antigen Testing Remain Relevant in the Point-of-Care Testing Environment?
Key points
Introduction and background
Specific assay considerations
Personal perspectives and future prospects
Clinics care points
Disclosures
The Role of Point-of-Care Testing in Specific Populations
Key points
Introduction
Point-of-care testing for specific populations: the example of people living with human immunodeficiency virus
Usage of point-of-care testing in rural and resource-limited settings
Enduring gaps in point-of-care test access
Summary
Disclosure
Clinics care points
Point-of-Care Testing for Sexually Transmitted Infections
Key points
Introduction
Trichomonas vaginalis
Gonorrhea and chlamydia
Human Immunodeficiency Virus (HIV)
Syphilis
Human papilloma virus
Herpes simplex virus
Bacterial vaginosis
Sexually transmitted infection at-home, self-testing
The future of sexually transmitted infection point-of-care testing
Clinics care points
Disclosure
Point-of-Care Testing for the Diagnosis of Fungal Infections: Current Testing Applications and Potential for the Future
Key points
Introduction
Discussion
What might the future hold for fungal point-of-care testing?
Summary
Disclosure
Hot Topics in Cancer Testing and New Developments
Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes: Comprehensive Pathologic, Clinical, and Molecular Review
Key points
Overview
Pathology
Molecular alterations and target therapy
Tumor microenvironment and immunotherapy
Treatment
Prognosis
Clinics care points
Update on Ovarian Sex Cord–Stromal Tumors
Key points
Introduction
Pure stromal tumors
Pure sex cord tumors
Mixed sex cord–stromal tumors
Clinics care points
Kidney Tumors: New and Emerging Kidney Tumor Entities
Key points
Eosinophilic solid and cystic renal cell carcinoma
Renal cell carcinoma with fibromyomatous stroma
Anaplastic lymphoma kinase-rearranged renal cell carcinoma
Eosinophilic vacuolated tumor
Low-grade oncocytic tumor
Thyroid-like follicular renal cell carcinoma
Biphasic hyalinizing psammomatous renal cell carcinoma
Summary
Disclosure
Dedication
A New Landscape of Testing and Therapeutics in Metastatic Breast Cancer
Key points
Overview
Hormone receptor and human epidermal growth factor receptor-2 testing
Programmed death-ligand 1 testing for immunotherapy
Mismatch repair protein deficiency, microsatellite instability, and tumor mutation burden testing
Single-gene alteration testing for targeted therapy
Future directions
Summary